A Study of Blood Pressure Control During Cancer Treatment

计划入组 130 人 · 首次发布于 2023 年 9 月 5 日

Antihypertensive Medications and the Risk of Sepsis

计划入组 1,129,062 人 · 首次发布于 2014 年 9 月 25 日

Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis

计划入组 131 人 · 首次发布于 2017 年 11 月 1 日

ADE-HYPT

JDP-202

BR-9201

CONTROLLED MEDICATIONS LIMITED

Hong Kong, China

PFIZER INC.

United States

Incyte Corporation

United States

Single Injection of Zilebesiran Reduces Blood Pressure by Up to 12 mmHg in Phase 2 Trial

Aprocitentan Demonstrates Efficacy in Treatment-Resistant Hypertension: PRECISION Trial Results

Aprocitentan Shows Promising Results in Black Adults with Resistant Hypertension